Watch this on-demand webinar to learn how to perform untargeted/semi-targeted metabolomic studies to discover novel biomarkers by mass spectrometry
The partnership aims to expand existing Monocyte Distribution Width (MDW) hematology-based biomarker to potentially aid in the rapid detection of MIS-C
The test uses a convolutional neural network to classify microscopy images of single intact particles of different viruses
In combination with other COVID-19 diagnostic tests, the Elecsys SARS-CoV-2 Antigen test can help in the management of patients for optimal care delivery
Miele’s latest range of professional washing machines and dryers promise to set new standards for the hygienic laundering of lab coats and protective clothing
Availability of the new IgM blood test on the ARCHITECT and Alinity platforms is part of Abbott's effort to offer tests across the disease progression of COVID-19
Easy-to-use test, which doesn't require specialized laboratory personnel or instruments, promises flexibility to test in locations that benefit from immediate results
The CTS Rotea system aims to help researchers overcome manufacturing hurdles and bring the vast potential of cell therapies to more patients
Find out how experts at the Ellison Institute are harnessing new cell monitoring technology to build cancer cell biobanks and enhance cell line quality control and authentication
Explore exclusive interviews, methods, and free downloads to help you optimize your mass spectrometry experiments
Join us on Thursday, October 29, to learn about the crucial role of food authenticity testing
Partnership combines Twist’s leadership in DNA synthesis and synthetic biology with Neogene’s expertise in personalized engineered T cell therapies
Summa Equity Fund II acquires a majority stake in Sengenics, a functional proteomics company with a unique technology for production of full-length, correctly folded and functional proteins
Antibodies available are specific for S1, S2 and receptor-binding domain regions of SARS-CoV-2 Spike protein
The CleanPlex ACE2 & TMPRSS2 Panel assesses differences in patients’ genetic susceptibility to COVID-19 infection and to developing severe disease
Find out how to rapidly test for multiple disease-causing microorganisms with syndromic panel-based testing
Join us on Monday, October 26, to learn about the role serology plays in the clinician toolbox for managing COVID-19
The DeNovix CellDrop™ Automated Cell Counter has been awarded the Gold Seal of Quality based on outstanding scientist reviews
EpiMOGRIFY supports the development of scalable off-the-shelf cell therapies for diseases with a high unmet clinical need
